United States · FDA National Drug Code directory
Palonosetron
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67184-0515_abeff9bd-6829-445c-93b8-3d9217993b9c
- Product NDC
- 67184-0515
- Form
- INJECTION
- Composition / generic term
- Palonosetron Hydrochloride
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180919
- Source listing expiry
- 20261231
Source-listed ingredients
- PALONOSETRON HYDROCHLORIDE — .075 mg/1.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 VIAL in 1 CARTON (67184-0515-2) / 1.5 mL in 1 VIAL (67184-0515-1) · 67184-0515-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →